| Sanofi-Aventis (Suisse) SA - Stilnox CR 12.5 mg, comprimés à libération contrôlée | | 57409 | | 02 | | Stilnox CR 12.5 mg | | comprimés à libération contrôlée | | N05CF02 | | Zolpidem | | 16.12.2005 | | |
| | Composition | | zolpidemi tartras 12.5 mg, lactosum monohydricum 138.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hypromellosum, magnesii stearas, silica colloidalis anhydrica, kalii hydrogenotartras, macrogolum 3350, E 132, E 171, E 172 (flavum), pro compresso obducto corresp. natrium max. 0.25 mg. | | Packungsbestandteile | | comprimés à libération contrôlée | | | | | Active Agent | Dose |
|---|
| Zolpidem Tartrate | 12.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Zolpidemi Tartras (2:1) | 12.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Kalii Hydrogenotartras | | | | Lactose Monohydrate | 138.9 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
